Document Detail


Single-dose systemic methotrexate for the treatment of persistent ectopic pregnancy after conservative surgery.
MedLine Citation:
PMID:  8272308     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine whether a single outpatient methotrexate injection successfully treats persistent ectopic pregnancy. METHODS: Nineteen consecutive patients with increasing beta-hCG titers after conservative surgery for ectopic pregnancy were treated with a single intramuscular methotrexate (50 mg/m2) injection. RESULTS: All 19 patients had resolution of their beta-hCG titers without subsequent surgery. Beta-hCG levels commonly increased during the first 3 days after treatment, but subsequently declined. Two patients required hospital admission for observation and analgesia. One of these two patients had probable self-limited intra-abdominal bleeding and required a blood transfusion. CONCLUSION: A single methotrexate injection is a safe and successful treatment for persistent ectopic pregnancy. Delayed hemorrhage may be a rare complication, and close surveillance is necessary.
Authors:
D E Hoppe; B E Bekkar; C W Nager
Related Documents :
1534728 - Methotrexate for treatment of unruptured ectopic pregnancy.
8682668 - Maintenance of effects in the nonmedical treatment of headaches during pregnancy.
12828878 - Headache in pregnancy.
12731748 - Early ultrasonographic diagnosis of unruptured interstitial pregnancy: a case report an...
2526758 - Maternal and embryonal/fetal beta-endorphin concentrations during the first trimester o...
25454988 - Maternal immunization to benefit the mother, fetus, and infant.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  83     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1994 Jan 
Date Detail:
Created Date:  1994-01-28     Completed Date:  1994-01-28     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  51-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Reproductive Medicine, University of California, School of Medicine, San Diego.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chorionic Gonadotropin / blood
Female
Humans
Methotrexate / administration & dosage*,  therapeutic use
Pregnancy
Pregnancy, Ectopic / blood,  drug therapy*,  surgery
Treatment Failure
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Postmenopausal hormone use and cholecystectomy in a large prospective study.
Next Document:  An updated protocol for abortion surveillance with ultrasound and immediate pathology.